Treatment results of pathological fractures of the long bones in patients with breast cancer
Abstract
Background. To analyze results of surgical treatment of pathological fractures in patients with long bones metastasis from breast cancer.
Methods. 22 patients with pathological fractures of the long bones were analyzed retrospectively. methods of bone reconstruction were intramedullary and plate osteosynthesis (53,8%), arthroplasty (46,2%).
Results. The overall survival was 66,2% at 1 year and 36,0% at 3 years (the mean survival time was 16,6 months). Visceral metastases have exerted statistically significant negative impact on survival (p=0,011). The complication rate after surgery was 27,3%. Quality of life and extremity function were significantly improved after surgical treatment (p=0,005).
Conclusions. active surgical treatment of long bone pathological fractures in patients with breast cancer allows to improve quality of life, get good functional results and make conditions for special treatment.
About the Authors
A. I. Radchenko
N.N. Alexandrov National Cancer Center of Belarus
Belarus
Belarus
Minsk
A. G. Zhukovec
N.N. Alexandrov National Cancer Center of Belarus
Belarus
Belarus
Minsk
Ju. M. Bogdaev
N.N. Alexandrov National Cancer Center of Belarus
Belarus
Belarus
Minsk
References
1. Океанов А.Е., Моисеев П.И., Левин Л.Ф. Статистика онкологических заболеваний. Минск: РНПЦ ОМР. 2013, 124 с.
2. Sogaard K.K., Cronin Fenton D.P., Pedersen L. et al. Survival in Danish patients with breast cancer and inflammatory bowel disease: a nationwide cohort study. Inflamm. Bowel. Dis. 2008, v. 14, p. 519-525.
3. Coleman R.E. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin. Cancer Res. 2006, v. 12, p. 6243-6249.
4. Jensen A.O., Jacobsen J.B., Norgaard M. et al. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer. 2011, v. 11, p. 329-338.
5. Saad F., Lipton A., Cook R. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer. 2007, v. 110 (8), p. 1860-1867.
6. Lipton A., Theriault R.L., Hortobagyi G.N. et al. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases. Cancer. 2000, v. 88, p. 1082-1090.
7. Hortobagyi G.N., Theriault R.L., Lipton A. et al. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate, Protocol 19, Aredia Breast Cancer Study Group. J. Clin. Oncol. 1998, v. 16, p. 2038-2044.
8. Hortobagyi G.N., Theriault R.L., Porter L. et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N. Engl. J. Med. 1996, v. 335, p. 1785-1791.
9. Hird et al. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers. Int. J. Radiat. Oncol. Biol. Phys. 2009, v. 75, p. 193-197.
10. Hamouda et al. Single versus conventional fractionated radiotherapy in the palliation of painful bone metastases. Gulf. J. Oncolog. 2007, v. 1, p. 35-41.
11. Hartsell et al. Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases. J. Nat. Cancer Inst. 2005, v. 97, p. 798-804.
12. Liepe et al. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases. Nucl. Med. Commun. 2007, v. 28, p. 623-630.
13. Liepe et al. Systemic radionuclide therapy in pain palliation. Am. J. Hosp. Palliat. Care. 2005, v. 22, p. 457-464.
14. Wedin R., Bauer H.C., Rutqvist L.E. Surgical treatment for skeletal breast cancer metastases: a population-based study of 641 patients. Cancer. 2001, v. 92 (2), p. 257-262.
15. Choi B.S., Robins H.I. Primary disease resection in metastatic breast cancer improves survival. J. Clin. Oncol. 2007, v. 25 (5), p. 603-604.
16. Jubelirer S.J., Wilson R., Summers L., Richardson S. Prognostic factors determining survival in breast cancer patients presenting with metastatic disease. W. V. Med. J. 1990, v. 86 (1), p. 7-9.
17. Bauer H.C., Wedin R. Survival after surgery for spinal and extremity metastases. Prognosticationin 241 patients. Acta Orthop. Scand. 1995, v. 66, p. 143-146.
18. Тепляков В.В., Амирасланов А.Т., Карпенко В.Ю. с соавт. Современные подходы к хирургическому лечению метастазов злокачественных опухолей в кости. Вопросы онкологии. 2005, № 3, с. 377-381.
19. Sukirtha T. et al. Quality of life measurement in bone metastases: a literature review. Journal of pain research. 2008, v. 1, p. 49-58.
Review
For citations:
Radchenko A.I., Zhukovec A.G., Bogdaev J.M. Treatment results of pathological fractures of the long bones in patients with breast cancer. Bone and soft tissue sarcomas, tumors of the skin. 2016;(3):11-15. (In Russ.)
Views:
85
Email this article 
